FY2025 EPS Estimate for Gilead Sciences Boosted by Analyst
Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) – Investment analysts at Cantor Fitzgerald lifted their FY2025 earnings per share estimates for shares of Gilead Sciences in a research report issued on Wednesday, February 19th. Cantor Fitzgerald analyst O. Brayer now expects that the biopharmaceutical company will earn $7.98 per share for the year, up from […]
Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) – Investment analysts at Cantor Fitzgerald lifted their FY2025 earnings per share estimates for shares of Gilead Sciences in a research report issued on Wednesday, February 19th. Cantor Fitzgerald analyst O. Brayer now expects that the biopharmaceutical company will earn $7.98 per share for the year, up from […]
